[go: up one dir, main page]

NO20003825L - 1,3,4 - oxadiazolonderivater - Google Patents

1,3,4 - oxadiazolonderivater

Info

Publication number
NO20003825L
NO20003825L NO20003825A NO20003825A NO20003825L NO 20003825 L NO20003825 L NO 20003825L NO 20003825 A NO20003825 A NO 20003825A NO 20003825 A NO20003825 A NO 20003825A NO 20003825 L NO20003825 L NO 20003825L
Authority
NO
Norway
Prior art keywords
oxadiazolone derivatives
oxadiazolone
derivatives
Prior art date
Application number
NO20003825A
Other languages
English (en)
Other versions
NO20003825D0 (no
NO317102B1 (no
Inventor
Piyasena Hewawasam
Min Ding
Jr John E Starret
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of NO20003825D0 publication Critical patent/NO20003825D0/no
Publication of NO20003825L publication Critical patent/NO20003825L/no
Publication of NO317102B1 publication Critical patent/NO317102B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/10—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
    • C07D271/113—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NO20003825A 1998-01-29 2000-07-26 1,3,4 - oxadiazolonderivater NO317102B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7296698P 1998-01-29 1998-01-29
US10227498P 1998-09-29 1998-09-29
PCT/US1999/000910 WO1999038510A1 (en) 1998-01-29 1999-01-15 Derivatives of 1,3,4-oxadiazolone

Publications (3)

Publication Number Publication Date
NO20003825D0 NO20003825D0 (no) 2000-07-26
NO20003825L true NO20003825L (no) 2000-07-26
NO317102B1 NO317102B1 (no) 2004-08-09

Family

ID=26753969

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20003825A NO317102B1 (no) 1998-01-29 2000-07-26 1,3,4 - oxadiazolonderivater

Country Status (27)

Country Link
US (1) US6034113A (no)
EP (1) EP1051173A4 (no)
JP (1) JP2002527352A (no)
KR (1) KR20010077838A (no)
CN (1) CN1150175C (no)
AR (1) AR010712A1 (no)
AU (1) AU735704B2 (no)
BG (1) BG104706A (no)
BR (1) BR9913010A (no)
CA (1) CA2318830A1 (no)
CO (1) CO5090837A1 (no)
EE (1) EE04089B1 (no)
GE (1) GEP20032914B (no)
HU (1) HUP0102025A3 (no)
ID (1) ID26909A (no)
IL (1) IL137518A0 (no)
LT (1) LT4838B (no)
LV (1) LV12559B (no)
NO (1) NO317102B1 (no)
NZ (1) NZ505409A (no)
PL (1) PL342060A1 (no)
RU (1) RU2202548C2 (no)
SK (1) SK10852000A3 (no)
TR (1) TR200002019T2 (no)
TW (1) TW550075B (no)
UA (1) UA58579C2 (no)
WO (1) WO1999038510A1 (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1056731A4 (en) * 1998-01-29 2002-07-31 Bristol Myers Squibb Co AMINOACID DERIVATIVES OF DIARYL 1,3,4-OXADIAZOLONE
US6297241B1 (en) 1999-01-29 2001-10-02 Bristol-Myers Squibb Company Carbamate derivatives of diaryl 1,3,4-oxadiazolone
US6162817A (en) * 1999-01-29 2000-12-19 Bristol-Myers Squibb Company Carbamate derivatives of diaryl 1,3,4-oxadiazolone
US6326388B1 (en) * 1999-12-21 2001-12-04 Celgene Corporation Substituted 1,3,4-oxadiazoles and a method of reducing TNF-alpha level
US6855829B2 (en) 2001-02-20 2005-02-15 Bristol-Myers Squibb Company 3-fluoro-2-oxindole modulators of KCNQ potassium channels and use thereof in treating migraine and mechanistically related disease
JP4073786B2 (ja) * 2001-04-16 2008-04-09 田辺三菱製薬株式会社 高コンダクタンス型カルシウム感受性ｋチャネル開口薬
US6909027B1 (en) * 2001-08-13 2005-06-21 Perry Robins Method of forming an in-situ film dressing and the composition of the film-forming material
US7119246B2 (en) * 2002-06-25 2006-10-10 Perry Robins Method of treating acne
KR102332837B1 (ko) 2012-01-18 2021-12-01 테크필즈 파마 코., 엘티디. 폐 병태의 치료를 위한 고침투 전구약물 조성물 및 그의 약제학적 조성물
JP5855599B2 (ja) * 2013-04-30 2016-02-09 テックフィールズ バイオケム カンパニー リミテッド 非常に速い皮膚浸透率を有するアセトアミノフェン及び関連化合物の正荷電水溶性プロドラッグ
CN104710379B (zh) * 2015-03-09 2017-01-18 华南理工大学 一种bms‑191011的合成方法
JP6165816B2 (ja) * 2015-10-01 2017-07-19 テックフィールズ バイオケム カンパニー リミテッド 非常に速い皮膚浸透率を有するアセトアミノフェン及び関連化合物の正荷電水溶性プロドラッグ
JP2020508328A (ja) * 2017-02-24 2020-03-19 オービッド・セラピューティクス・インコーポレイテッドＯｖｉｄ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｉｎｃ． 発作性障害の治療方法
EP3870159B1 (en) 2018-10-26 2024-11-13 University of South Florida Drug for treating tinnitus
CN110987847B (zh) * 2019-12-11 2021-02-19 苏州今蓝纳米科技有限公司 1,3,4-噁二唑衍生物在检测酸以及数据加密和储存中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH583213A5 (no) * 1973-05-21 1976-12-31 Ciba Geigy Ag
IT1251488B (it) * 1991-09-17 1995-05-15 Mini Ricerca Scient Tecnolog Ossa(tia)diazol- e triazol-oni(tioni) ad attivita' acaricida ed insetticida
US5234947A (en) * 1991-11-07 1993-08-10 New York University Potassium channel activating compounds and methods of use thereof
US5547966A (en) * 1993-10-07 1996-08-20 Bristol-Myers Squibb Company Aryl urea and related compounds
TW467902B (en) * 1996-07-31 2001-12-11 Bristol Myers Squibb Co Diphenyl heterocycles as potassium channel modulators
EP1056731A4 (en) * 1998-01-29 2002-07-31 Bristol Myers Squibb Co AMINOACID DERIVATIVES OF DIARYL 1,3,4-OXADIAZOLONE

Also Published As

Publication number Publication date
ID26909A (id) 2001-02-15
NZ505409A (en) 2003-08-29
KR20010077838A (ko) 2001-08-20
LV12559A (en) 2000-11-20
NO20003825D0 (no) 2000-07-26
BG104706A (en) 2001-04-30
TW550075B (en) 2003-09-01
AU735704B2 (en) 2001-07-12
GEP20032914B (en) 2003-03-25
EE04089B1 (et) 2003-08-15
CA2318830A1 (en) 1999-08-05
CO5090837A1 (es) 2001-10-30
LT4838B (lt) 2001-08-27
UA58579C2 (uk) 2003-08-15
LV12559B (en) 2001-04-20
BR9913010A (pt) 2001-05-08
NO317102B1 (no) 2004-08-09
CN1150175C (zh) 2004-05-19
IL137518A0 (en) 2001-07-24
HUP0102025A2 (hu) 2001-11-28
WO1999038510A1 (en) 1999-08-05
EP1051173A1 (en) 2000-11-15
PL342060A1 (en) 2001-05-21
TR200002019T2 (tr) 2000-11-21
LT2000068A (en) 2001-03-26
SK10852000A3 (sk) 2002-02-05
AU2230899A (en) 1999-08-16
CN1289249A (zh) 2001-03-28
AR010712A1 (es) 2000-07-12
EE200000447A (et) 2001-12-17
EP1051173A4 (en) 2002-07-31
RU2202548C2 (ru) 2003-04-20
HUP0102025A3 (en) 2002-01-28
JP2002527352A (ja) 2002-08-27
US6034113A (en) 2000-03-07

Similar Documents

Publication Publication Date Title
DE69933287D1 (de) 12,13-modifizierte epothilon-derivate
ID29241A (id) Turunan-turunan kinolin teranelasi-1,2
ATE340176T1 (de) Substituierte 6,5-heterobicyclische-derivate
DK0925298T3 (da) Substituerede 6,6-heterobicykliske derivater
DK1000048T3 (da) Substituerede 1,2,3,4-tetrahydronapthalenderivater
NO20010193L (no) Tiobenzimidazol-derivater
DK0930302T3 (da) Benzosulfonderivater
NO20010514D0 (no) Aminometylkarboksylsyre-derivater
ATE259810T1 (de) Phenyl-xanthinderivate
ATE231847T1 (de) Substituierte 1,2,3,4- tetrahydronaphthalinderivate
DK1140835T3 (da) 3,3-biarylpiperidin- og 2,2-biarylmorpholon-derivater
EE04089B1 (et) 1,3,4-oksadiasolooni derivaadid
DE60025958D1 (de) 14,15-beta-methylen substituierte androgene
DK1115716T3 (da) 2-phenylpyran-4-on-derivater
DK1134219T3 (da) Cucloalkylsubstituerede aminomethylpyrrolidinderivater
ATE233253T1 (de) Chromanderivate
DK1149106T3 (da) 4,5-azolo-oxindoler
DK1060183T3 (da) 5-deoxycytidinderivater
ID26368A (id) Turunan-turunan 2 deoksi higromisin
ATE240941T1 (de) 1,25-dihydroxy-16,22,23-trisdehydro- cholecalciferol-derivate
DE59907635D1 (de) Pyrazolyldioxothiochromanoyl-derivate

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees